JP2003519190A - 水性イオン性溶液及び、特に眼科学におけるその使用 - Google Patents
水性イオン性溶液及び、特に眼科学におけるその使用Info
- Publication number
- JP2003519190A JP2003519190A JP2001549672A JP2001549672A JP2003519190A JP 2003519190 A JP2003519190 A JP 2003519190A JP 2001549672 A JP2001549672 A JP 2001549672A JP 2001549672 A JP2001549672 A JP 2001549672A JP 2003519190 A JP2003519190 A JP 2003519190A
- Authority
- JP
- Japan
- Prior art keywords
- seawater
- aqueous ionic
- solution
- hand
- ionic solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013535 sea water Substances 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 235000002639 sodium chloride Nutrition 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229940023490 ophthalmic product Drugs 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 238000010612 desalination reaction Methods 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- -1 and Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 26
- 238000005259 measurement Methods 0.000 description 11
- 210000000795 conjunctiva Anatomy 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 239000011575 calcium Substances 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 206010015946 Eye irritation Diseases 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 231100000013 eye irritation Toxicity 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 231100000635 Draize test Toxicity 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000909 electrodialysis Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 2
- 210000000554 iris Anatomy 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- 102100031083 Uteroglobin Human genes 0.000 description 1
- 108090000203 Uteroglobin Proteins 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000269 corneal opacity Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR99/16814 | 1999-12-31 | ||
| FR9916814A FR2803205B1 (fr) | 1999-12-31 | 1999-12-31 | Solutions ioniques aqueuses et leurs utilisations notamment en ophtalmologie |
| PCT/FR2000/003709 WO2001049304A2 (fr) | 1999-12-31 | 2000-12-28 | Solutions ioniques aqueuses et leurs utilisations notamment en ophtalmologie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003519190A true JP2003519190A (ja) | 2003-06-17 |
| JP2003519190A5 JP2003519190A5 (enExample) | 2008-08-14 |
Family
ID=9554118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001549672A Pending JP2003519190A (ja) | 1999-12-31 | 2000-12-28 | 水性イオン性溶液及び、特に眼科学におけるその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20030152645A1 (enExample) |
| EP (1) | EP1242098B1 (enExample) |
| JP (1) | JP2003519190A (enExample) |
| AT (1) | ATE368468T1 (enExample) |
| AU (1) | AU3029501A (enExample) |
| CA (1) | CA2396045C (enExample) |
| DE (1) | DE60035799T2 (enExample) |
| FR (1) | FR2803205B1 (enExample) |
| PT (1) | PT1242098E (enExample) |
| WO (1) | WO2001049304A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2843029B1 (fr) * | 2002-08-02 | 2006-05-26 | Goemar Lab Sa | Solution de rincage pour lentilles de contact |
| ITMI20022353A1 (it) * | 2002-11-06 | 2004-05-07 | Farmaceutici S R L | Composizione di un preparato per gli occhi con attivita' antiallergica, antibatterica e disarrossante. |
| FR2872046B1 (fr) * | 2004-06-28 | 2006-09-15 | Pascal Hemmery | Compostion a base d'eau de mer, son procede de preparation, son utilisation pour l'hygiene de l'appareil genital feminin et dispositif pour son utilisation |
| FR2905267B1 (fr) * | 2006-09-05 | 2012-02-17 | Yslab | Solution a ionisation controlee a base d'eau de mer, destine a l'ophtalmologie. |
| FR2915389B1 (fr) * | 2007-04-26 | 2012-12-21 | De La Mer Laboratoire | Utilisation de solutions ioniques isoosmotiques a base d'eau de mer pour la fabrication de dispositifs medicaux pour la prevention des complications du rhume courant |
| FR2971713B1 (fr) | 2011-02-18 | 2019-03-29 | Laboratoire De La Mer | Solution ionique aqueuse contenant de l'eau de mer et au moins un compose originellement non miscible a l'eau de mer. |
| FR3005264B1 (fr) * | 2013-05-03 | 2015-05-15 | Ys Lab | Solution marine enrichie en zinc et en potassium |
| CN109260221A (zh) * | 2013-07-17 | 2019-01-25 | 银川高新区广煜科技有限公司 | 纯天然成分的眼药水及其制备和使用方法 |
| IT201600078342A1 (it) * | 2016-07-26 | 2018-01-26 | Farm S R L C U S | Processo per la ristrutturazione idroionica delle acque termali e marine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4581226A (en) * | 1983-04-07 | 1986-04-08 | Dillon Richard S | Method of treating sensitive animal tissue with a specially processed seawater solution |
| WO1999058095A2 (fr) * | 1998-05-14 | 1999-11-18 | Sephra S.A.R.L. | Compositions pharmaceutiques et/ou cosmetiques contenant de l'eau de mer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735980B1 (fr) * | 1995-06-30 | 1997-09-12 | Sun Trading Ltd | Nouvelles preparations pour l'otologie et leur procede de preparation |
| FR2780284B1 (fr) * | 1998-06-29 | 2001-10-05 | Goemar Lab Sa | Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments cerumenolytiques a base de ces solutions |
| FR2780285B1 (fr) * | 1998-06-29 | 2001-10-05 | Goemar Lab Sa | Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments anti-inflammatoires a base de ces solutions |
-
1999
- 1999-12-31 FR FR9916814A patent/FR2803205B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-28 US US10/169,284 patent/US20030152645A1/en not_active Abandoned
- 2000-12-28 PT PT00990830T patent/PT1242098E/pt unknown
- 2000-12-28 WO PCT/FR2000/003709 patent/WO2001049304A2/fr not_active Ceased
- 2000-12-28 EP EP00990830A patent/EP1242098B1/fr not_active Expired - Lifetime
- 2000-12-28 AU AU30295/01A patent/AU3029501A/en not_active Abandoned
- 2000-12-28 DE DE60035799T patent/DE60035799T2/de not_active Expired - Lifetime
- 2000-12-28 AT AT00990830T patent/ATE368468T1/de not_active IP Right Cessation
- 2000-12-28 CA CA2396045A patent/CA2396045C/fr not_active Expired - Fee Related
- 2000-12-28 JP JP2001549672A patent/JP2003519190A/ja active Pending
-
2005
- 2005-05-23 US US11/135,113 patent/US7700077B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4581226A (en) * | 1983-04-07 | 1986-04-08 | Dillon Richard S | Method of treating sensitive animal tissue with a specially processed seawater solution |
| WO1999058095A2 (fr) * | 1998-05-14 | 1999-11-18 | Sephra S.A.R.L. | Compositions pharmaceutiques et/ou cosmetiques contenant de l'eau de mer |
Also Published As
| Publication number | Publication date |
|---|---|
| US7700077B2 (en) | 2010-04-20 |
| FR2803205B1 (fr) | 2002-10-18 |
| US20030152645A1 (en) | 2003-08-14 |
| CA2396045C (fr) | 2010-09-21 |
| US20060003025A1 (en) | 2006-01-05 |
| DE60035799D1 (de) | 2007-09-13 |
| DE60035799T2 (de) | 2008-04-30 |
| EP1242098B1 (fr) | 2007-08-01 |
| ATE368468T1 (de) | 2007-08-15 |
| EP1242098A2 (fr) | 2002-09-25 |
| WO2001049304A3 (fr) | 2002-05-23 |
| AU3029501A (en) | 2001-07-16 |
| WO2001049304A2 (fr) | 2001-07-12 |
| PT1242098E (pt) | 2007-10-31 |
| CA2396045A1 (fr) | 2001-07-12 |
| FR2803205A1 (fr) | 2001-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0648114B1 (de) | Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels | |
| JP2571312B2 (ja) | ヒアルロン酸会合物を含む新規組成物及びそれを調製するための方法 | |
| EP1453523B1 (de) | Heparin-haltiges ophthalmikum | |
| JP2003519190A (ja) | 水性イオン性溶液及び、特に眼科学におけるその使用 | |
| Lander et al. | Orbicularis oculi muscle fibers are relatively short and heterogeneous in length. | |
| CN114432170A (zh) | 一种温和的宠物用沐浴露及其制备工艺 | |
| JPH05117158A (ja) | 皮膚外用剤組成物 | |
| US5200180A (en) | Pharmaceutical composition for the treatment of the human eye | |
| US5215760A (en) | Saturated solution of purified sodium chloride in purified aloe vera for inducing and stimulating hair growth and for decreasing hair loss | |
| JPS61233622A (ja) | 眼薬組成物 | |
| Remuzzi et al. | Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats | |
| Smolin et al. | Tretinoin and corneal epithelial wound healing | |
| US20030228374A1 (en) | Topical treatment for skin irritation | |
| RU2092156C1 (ru) | Раствор для стимуляции репарации кожи "коллагель" | |
| DE10360425A1 (de) | Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung | |
| DE1667890C3 (de) | Dermatologische und kosmetische äußerlich anzuwendende Mittel zur Be handlung von Hautkollagenosen | |
| JPS62209010A (ja) | 化粧料 | |
| DE3441835C2 (enExample) | ||
| Tucker Jr et al. | Preclinical toxicology studies with acyclovir: ophthalmic and cutaneous tests | |
| CN114099551B (zh) | 缓解视疲劳润眼组合物 | |
| RU2134559C1 (ru) | Глазные капли "корнеалон" | |
| JP3138399B2 (ja) | ボディリンス浴用剤 | |
| JPH10316575A (ja) | 表皮角質化促進剤 | |
| JPH03258724A (ja) | 知覚過敏抑制剤 | |
| CN104906037A (zh) | 一种重组水蛭素滴眼液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070815 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080624 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20081003 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101102 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110128 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110204 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110428 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110607 |